The shareholders of CombiGene AB (publ) (“CombiGene” or the “Company”) have previously been given notice to attend the Extraordinary General Meeting on 10 December 2024 at 13.30 CET via digital connection. The following is supplemented with further information regarding the shareholder Strategic Partner A/S’s proposal for election of Board members, deputy Board member and Chairman of the Board.
The shareholder Strategic Partner A/S proposes that Luca Di Stefano and Jakob Bendtsen be elected as new Board members, that Marcus Isaksson be re-elected as Board member and that Lars Thunberg be elected as new deputy Board member. Luca Di Stefano is proposed as Chairman of the Board. The proposal means that Jonas Ekblom, Gunilla Lundmark, Peter Nilsson, Per Lundin, and Malin Almgren are replaced as Board members.
Luca Di Stefano
Born: 1978
Luca holds a degree in Market Economy from Frans Schartau Business Institute and International Relations from Stockholm University. Luca is an investor, Board professional, and founder of several companies in media and IT. Since 2017, also held an active role as CEO/operational manager and Board member of several growth companies. Most recently, he was co-owner and CEO of the digital marketing agency Brandson AB, which was later acquired by Defiso Media AB.
Luca is Chairman of the Board and Board member of the listed companies Tellusgruppen AB, Refine Group AB and Upgrade Invest Nordic AB. He is also a Board member of several private investment/consulting companies such as XLNT group AB, Mresell Group AB and Hamax Holding AB. Luca is currently responsible for the Swedish investment company Molcap and oversees their unlisted portfolio.
Luca does not hold any shares in CombiGene and is independent in relation to the Company and its senior management but not in relation to major shareholders.
Jakob Bendtsen
Born: 1978
Education and experience: Jakob holds and academic audit and accounting degree from Copenhagen Business School in Denmark. He has worked over 25 years in the audit, accounting, tax advisory and general consulting sector. Jakob has previously held senior financial and accounting roles in various companies in Denmark and US. He was previously a Board member of the Danish companies Rovsing A/S and Nordic Compound Invest A/S.
Board director and CEO in the Danish company Strategic Partners A/S as well as CEO in Cewijo ApS.
Jakob does not hold any shares in CombiGene and is independent in relation to the Company and its senior management but not in relation to major shareholders.
Lars Thunberg
Born: 1966
Lars holds an academic degree in business administration from Lunds University. He has over 30 years of experience in finance and company development. He has worked for NGM Stock market as consultant to start ups. He also has working experience as business developer and as a Board professional. Lars was one of the founders of CombiGene. Lars also founded VA Automotive Groupe during the years 2008-2018 which was listed at Nasdaq First North Growth Market. Lars have international experience from working in Hong Kong, China and Europe.
Chairman of the Board and CEO of VA Components i Hässleholm AB, M & L Industriförvaltning AB, PR Development AB and Casator Care AB.
Lars hold through the closely related company M & L Industriförvaltning AB 650,000 shares in CombiGene. Lars is independent in relation to the Company, its senior management and major shareholders.